NEU 0.98% $19.50 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-948

  1. 61 Posts.
    lightbulb Created with Sketch. 8
    Apologies if this has been posted elsewhere already. Just watched this interview with Hashan from KP Rx which touched on NEU in a few areas, most notably around the 12:45 min mark for those interested. More broadly though I thought it gave an excellent insight into the biotech market in Australia and some very good advice on investing in the sector and things to look out for. Seems like he's got an impressive lineup of big name healthcare entrepreneurs supporting backing him - Patrick Davies, the Chairman of Neuren, as well as Chris Behrenbruch, the founder of Telix (around the 2 min mark.
    https://www.livewiremarkets.com/wires/backed-by-industry-titans-this-fundie-is-leveraging-australia-s-healthcare-innovation
    Last edited by Weddell: 01/05/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.50
Change
0.190(0.98%)
Mkt cap ! $2.490B
Open High Low Value Volume
$19.39 $19.98 $19.38 $7.285M 370.6K

Buyers (Bids)

No. Vol. Price($)
11 7318 $19.50
 

Sellers (Offers)

Price($) Vol. No.
$19.52 593 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$19.55
  Change
0.190 ( 0.83 %)
Open High Low Volume
$19.41 $19.97 $19.39 83274
Last updated 15.59pm 14/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.